Abstract
DNA damage response (DDR) is among the most important of the mechanisms that maintain genome stability which, when destabilized, predisposes organs to cancer. Reversible phosphorylation mediated by protein kinases and protein phosphatases regulates most, if not all, cellular activities, including DDR. Protein kinase inhibitors have become the main focus of targeted therapy and anticancer drug development. However, our limited knowledge of protein phosphatase function is compromising our capacity to develop therapeutic agents against phosphatases. In this review, we summarize the roles of serine/threonine protein phosphatases involved in DDR and propose that in situ dephosphorylation of phosphoproteins by protein phosphatases, instead of proteasome-mediated degradation of phosphoproteins, is mainly employed by cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bartsch H, Risch A, Schmezer P, et al. DNA damage from endogenous processes, workshop: 16–17 September 1996, German Cancer Research Centre Heidelberg, Germany. J Cancer Res Clin Oncol, 1997, 123: 232–234
Lindahl T, Barnes D E. Repair of endogenous DNA damage. Cold Spring Harb Symp Quant Biol, 2000, 65: 127–133
Valko M, Rhodes C J, Moncol J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact, 2006, 160: 1–40
Blasiak J, Arabski M, Krupa R, et al. Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer. Mutat Res, 2004, 554: 139–148
Friedberg E C, McDaniel L D, Schultz R A. The role of endogenous and exogenous DNA damage and mutagenesis. Curr Opin Genet Dev, 2004, 14: 5–10
Sinha R P, Hader D P. UV-induced DNA damage and repair: A review. Photochem Photobiol Sci, 2002, 1: 225–236
Kappes U P, Luo D, Potter M, et al. Short- and long-wave UV light (UVB and UVA) induce similar mutations in human skin cells. J Invest Dermatol, 2006, 126: 667–675
Madronich S, McKenzie R L, Bjorn L O, et al. Changes in biologically active ultraviolet radiation reaching the Earth’s surface. J Photochem Photobiol B, 1998, 46: 5–19
D’Arpa P, Liu L F. Topoisomerase-targeting antitumor drugs. Biochim Biophys Acta, 1989, 989: 163–177
Binaschi M, Capranico G, De Isabella P, et al. Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors. Int J Cancer, 1990, 45: 347–352
Azarova A M, Lyu Y L, Lin C P, et al. Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Proc Natl Acad Sci USA, 2007, 104: 11014–11019
Clemenson C, Marsolier-Kergoat M C. DNA damage checkpoint inactivation: Adaptation and recovery. DNA Repair (Amst), 2009, 8: 1101–1109
Kurz E U, Lees-Miller S P. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst), 2004, 3: 889–900
Su T T. Cellular responses to DNA damage: One signal, multiple choices. Annu Rev Genet, 2006, 40: 187–208
de Gruijl F R, van Kranen H J, Mullenders L H. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B, 2001, 63: 19–27
Helleday T, Petermann E, Lundin C, et al. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer, 2008, 8: 193–204
Liu T, Ghosal G, Yuan J, et al. FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science, 2010, 329: 693–696
Li X, Heyer W D. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res, 2008, 18: 99–113
Wang Q, Gao F, Wang T, et al. A nonhomologous end-joining pathway is required for protein phosphatase 2A promotion of DNA double-strand break repair. Neoplasia, 2009, 11: 1012–1021
Schwartz M, Zlotorynski E, Goldberg M, et al. Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev, 2005, 19: 2715–2726
Mladenov E, Kalev P, Anachkova B. The complexity of double-strand break ends is a factor in the repair pathway choice. Radiat Res, 2009, 171: 397–404
Harper J W, Elledge S J. The DNA damage response: Ten years after. Mol Cell, 2007, 28: 739–745
Ciccia A, Elledge S J. The DNA damage response: Making it safe to play with knives. Mol Cell, 2010, 40: 179–204
Kanaar R, Wyman C. DNA repair by the MRN complex: Break it to make it. Cell, 2008, 135: 14–16
Czornak K, Chughtai S, Chrzanowska K H. Mystery of DNA repair: The role of the MRN complex and ATM kinase in DNA damage repair. J Appl Genet, 2008, 49: 383–396
Matsuoka S, Ballif B A, Smogorzewska A, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science, 2007, 316: 1160–1166
Bakkenist C J, Kastan M B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature, 2003, 421: 499–506
Stucki M, Clapperton J A, Mohammad D, et al. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell, 2005, 123: 1213–1226
Marteijn J A, Bekker-Jensen S, Mailand N, et al. Nucleotide excision repair-induced H2A ubiquitination is dependent on MDC1 and RNF8 and reveals a universal DNA damage response. J Cell Biol, 2009, 186: 835–847
Shao G, Lilli D R, Patterson-Fortin J, et al. The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks. Proc Natl Acad Sci USA, 2009, 106: 3166–3171
Xu X, Stern D F. NFBD1/MDC1 regulates ionizing radiation-induced focus formation by DNA checkpoint signaling and repair factors. FASEB J, 2003, 17: 1842–1848
Ahn J Y, Schwarz J K, Piwnica-Worms H, et al. Threonine 68 phosphorylation by Ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res, 2000, 60: 5934–5936
Cohen P. The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture. Eur J Biochem, 2001, 268: 5001–5010
Olsen J V, Blagoev B, Gnad F, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell, 2006, 127: 635–648
Cozzone A J. Post-translational modification of proteins by reversible phosphorylation in prokaryotes. Biochimie, 1998, 80: 43–48
Manning G, Whyte D B, Martinez R, et al. The protein kinase complement of the human genome. Science, 2002, 298: 1912–1934
Manning G, Plowman G D, Hunter T, et al. Evolution of protein kinase signaling from yeast to man. Trends Biochem Sci, 2002, 27: 514–520
Alonso A, Sasin J, Bottini N, et al. Protein tyrosine phosphatases in the human genome. Cell, 2004, 117: 699–711
Moorhead G B, Trinkle-Mulcahy L, Ulke-Lemee A. Emerging roles of nuclear protein phosphatases. Nat Rev Mol Cell Biol, 2007, 8: 234–244
Gallego M, Virshup D M. Protein serine/threonine phosphatases: Life, death, and sleeping. Curr Opin Cell Biol, 2005, 17: 197–202
Andreeva A V, Kutuzov M A. PPP family of protein Ser/Thr phosphatases: Two distinct branches? Mol Biol Evol, 2001, 18: 448–452
Heideker J, Lis E T, Romesberg F E. Phosphatases, DNA damage checkpoints and checkpoint deactivation. Cell Cycle, 2007, 6: 3058–3064
Wehenkel A, Bellinzoni M, Schaeffer F, et al. Structural and binding studies of the three-metal center in two mycobacterial PPM Ser/Thr protein phosphatases. J Mol Biol, 2007, 374: 890–898
Cohen P. Protein kinases-the major drug targets of the twenty-first century? Nat Rev Drug Discov, 2002, 1: 309–315
Song Q, Khanna K K, Lu H, et al. Cloning and characterization of a human protein phosphatase 1-encoding cDNA. Gene, 1993, 129: 291–295
Fardilha M, Wu W, Sa R, et al. Alternatively spliced protein variants as potential therapeutic targets for male infertility and contraception. Ann N Y Acad Sci, 2004, 1030: 468–478
Barker H M, Craig S P, Spurr N K, et al. Sequence of human protein serine/threonine phosphatase 1 gamma and localization of the gene (PPP1CC) encoding it to chromosome bands 12q24.1-q24.2. Biochim Biophys Acta, 1993, 1178: 228–233
Trinkle-Mulcahy L, Sleeman J E, Lamond A I. Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells. J Cell Sci, 2001, 114: 4219–4228
Godet A N, Guergnon J, Maire V, et al. The combinatorial PP1-binding consensus Motif (R/K)x( (0,1))V/IxFxx(R/K)x(R/K) is a new apoptotic signature. PLoS One, 2010, 5: e9981
Hendrickx A, Beullens M, Ceulemans H, et al. Docking motif-guided mapping of the interactome of protein phosphatase-1. Chem Biol, 2009, 16: 365–371
Janssens V, Longin S, Goris J. PP2A holoenzyme assembly: In cauda venenum (the sting is in the tail). Trends Biochem Sci, 2008, 33: 113–121
Dohadwala M, da Cruze Silva E F, Hall F L, et al. Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases. Proc Natl Acad Sci USA, 1994, 91: 6408–6412
Guo C Y, Brautigan D L, Larner J M. Ionizing radiation activates nuclear protein phosphatase-1 by ATM-dependent dephosphorylation. J Biol Chem, 2002, 277: 41756–41761
Peng A, Lewellyn A L, Schiemann W P, et al. Repo-man controls a protein phosphatase 1-dependent threshold for DNA damage checkpoint activation. Curr Biol, 2010, 20: 387–396
Tang X, Hui Z G, Cui X L, et al. A novel ATM-dependent pathway regulates protein phosphatase 1 in response to DNA damage. Mol Cell Biol, 2008, 28: 2559–2566
Peng A, Lewellyn A L, Schiemann W P, et al. Repo-Man controls a protein phosphatase 1-dependent threshold for DNA damage checkpoint activation. Curr Biol, 2010, 20: 387–396
Margolis S S, Perry J A, Weitzel D H, et al. A role for PP1 in the Cdc2/Cyclin B-mediated positive feedback activation of Cdc25. Mol Biol Cell, 2006, 17: 1779–1789
Margolis S S, Walsh S, Weiser D C, et al. PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J, 2003, 22: 5734–5745
den Elzen N R, Kosoy A, Christopoulos H, et al. Resisting arrest: Recovery from checkpoint arrest through dephosphorylation of Chk1 by PP1. Cell Cycle, 2004, 3: 529–533
den Elzen N R, O’Connell M J. Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1. EMBO J, 2004, 23: 908–918
Hsu L C. Identification and functional characterization of a PP1-binding site in BRCA1. Biochem Biophys Res Commun, 2007, 360: 507–512
Winter S L, Bosnoyan-Collins L, Pinnaduwage D, et al. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. BMC Cancer, 2007, 7: 85
Yu Y M, Pace S M, Allen S R, et al. A PP1-binding motif present in BRCA1 plays a role in its DNA repair function. Int J Biol Sci, 2008, 4: 352–361
Haneda M, Kojima E, Nishikimi A, et al. Protein phosphatase 1, but not protein phosphatase 2A, dephosphorylates DNA-damaging stress-induced phospho-serine 15 of p53. FEBS Lett, 2004, 567: 171–174
Shieh S Y, Ikeda M, Taya Y, et al. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell, 1997, 91: 325–334
Tibbetts R S, Brumbaugh K M, Williams J M, et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev, 1999, 13: 152–157
Shieh S Y, Taya Y, Prives C. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J, 1999, 18: 1815–1823
Hirao A, Kong Y Y, Matsuoka S, et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science, 2000, 287: 1824–1827
Lee S J, Lim C J, Min J K, et al. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: Its role in post-translational modification of p53 and MDM2. Cell Death Differ, 2007, 14: 1106–1116
Eichhorn P J, Creyghton M P, Bernards R. Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta, 2009, 1795: 1–15
Inui S, Sanjo H, Maeda K, et al. Ig receptor binding protein 1 (alpha4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. Blood, 1998, 92: 539–546
Bosch M, Cayla X, van Hoof C, et al. The PR55 and PR65 subunits of protein phosphatase 2A from Xenopus laevis. Molecular cloning and developmental regulation of expression. Eur J Biochem, 1995, 230: 1037–1045
Shi Y. Assembly and structure of protein phosphatase 2A. Sci China C-Life Sci, 2009, 52: 135–146
Guenin S, Schwartz L, Morvan D, et al. PP2A activity is controlled by methylation and regulates oncoprotein expression in melanoma cells: A mechanism which participates in growth inhibition induced by chloroethylnitrosourea treatment. Int J Oncol, 2008, 32: 49–57
Avni D, Yang H, Martelli F, et al. Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage. Mol Cell, 2003, 12: 735–746
Dohoney K M, Guillerm C, Whiteford C, et al. Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage. Oncogene, 2004, 23: 49–57
Li H H, Cai X, Shouse G P, et al. A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55. EMBO J, 2007, 26: 402–411
Yan Y, Cao P T, Greer P M, et al. Protein phosphatase 2A has an essential role in the activation of gamma-irradiation-induced G2/M checkpoint response. Oncogene, 2010, 29: 4317–4329
Jang Y J, Ji J H, Choi Y C, et al. Regulation of Polo-like kinase 1 by DNA damage in mitosis: Inhibition of mitotic PLK-1 by protein phosphatase 2A. J Biol Chem, 2007, 282: 2473–2482
Margolis S S, Perry J A, Forester C M, et al. Role for the PP2A/ B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell, 2006, 127: 759–773
Douglas P, Moorhead G B, Ye R, et al. Protein phosphatases regulate DNA-dependent protein kinase activity. J Biol Chem, 2001, 276: 18992–18998
McConnell J L, Gomez R J, McCorvey L R, et al. Identification of a PP2A-interacting protein that functions as a negative regulator of phosphatase activity in the ATM/ATR signaling pathway. Oncogene, 2007, 26: 6021–6030
Chowdhury D, Xu X, Zhong X, et al. A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Mol Cell, 2008, 31: 33–46
O’Neill B M, Szyjka S J, Lis E T, et al. Pph3-Psy2 is a phosphatase complex required for Rad53 dephosphorylation and replication fork restart during recovery from DNA damage. Proc Natl Acad Sci USA, 2007, 104: 9290–9295
Veluthakal R, Wadzinski B E, Kowluru A. Localization of a nuclear serine/threonine protein phosphatase in insulin-secreting INS-1 cells: Potential regulation by IL-1beta. Apoptosis, 2006, 11: 1401–1411
Sumiyoshi E, Sugimoto A, Yamamoto M. Protein phosphatase 4 is required for centrosome maturation in mitosis and sperm meiosis in C. elegans. J Cell Sci, 2002, 115: 1403–1410
Lyu J, Jho E H, Lu W. Smek promotes histone deacetylation to suppress transcription of Wnt target gene brachyury in pluripotent embryonic stem cells. Cell Res, 2011, 21: 911–921
Gingras A C, Caballero M, Zarske M, et al. A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Mol Cell Proteomics, 2005, 4: 1725–1740
Kim J A, Hicks W M, Li J, et al. Protein phosphatases pph3, ptc2, and ptc3 play redundant roles in DNA double-strand break repair by homologous recombination. Mol Cell Biol, 2011, 31: 507–516
Nussenzweig A, Paull T. DNA repair: Tails of histones lost. Nature, 2006, 439: 406–407
Szyjka S J, Aparicio J G, Viggiani C J, et al. Rad53 regulates replication fork restart after DNA damage in Saccharomyces cerevisiae. Genes Dev, 2008, 22: 1906–1920
Nakada S, Chen G I, Gingras A C, et al. PP4 is a gamma H2AX phosphatase required for recovery from the DNA damage checkpoint. EMBO Rep, 2008, 9: 1019–1026
Lee D H, Pan Y, Kanner S, et al. A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via homologous recombination. Nat Struct Mol Biol, 2010, 17: 365–372
Wang B, Zhao A, Sun L, et al. Protein phosphatase PP4 is overexpressed in human breast and lung tumors. Cell Res, 2008, 18: 974–977
Bastians H, Ponstingl H. The novel human protein serine/threonine phosphatase 6 is a functional homologue of budding yeast Sit4p and fission yeast ppe1, which are involved in cell cycle regulation. J Cell Sci, 1996, 109(Pt12): 2865–2874
Stefansson B, Brautigan D L. Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IkappaBepsilon. J Biol Chem, 2006, 281: 22624–22634
Stefansson B, Ohama T, Daugherty A E, et al. Protein phosphatase 6 regulatory subunits composed of ankyrin repeat domains. Biochemistry, 2008, 47: 1442–1451
Guergnon J, Derewenda U, Edelson J R, et al. Mapping of protein phosphatase-6 association with its SAPS domain regulatory subunit using a model of helical repeats. BMC Biochem, 2009, 10: 24
Douglas P, Zhong J, Ye R, et al. Protein phosphatase 6 interacts with the DNA-dependent protein kinase catalytic subunit and dephosphorylates gamma-H2AX. Mol Cell Biol, 2010, 30: 1368–1381
Mi J, Dziegielewski J, Bolesta E, et al. Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase 6. PLoS One, 2009, 4: e4395
Douglas P, Moorhead G, Xu X, et al. Choreographing the DNA damage response: PP6 joins the dance. Cell Cycle, 2010, 9: 1221–1222
Zhong J, Liao J, Liu X, et al. Protein phosphatase PP6 is required for homology-directed repair of DNA double-strand breaks. Cell Cycle, 2011, 10: 1411–1419
Hinds T D Jr, Sanchez E R. Protein phosphatase 5. Int J Biochem Cell Biol, 2008, 40: 2358–2362
Ham B M, Jayachandran H, Yang F, et al. Novel Ser/Thr protein phosphatase 5 (PP5) regulated targets during DNA damage identified by proteomics analysis. J Proteome Res, 2010, 9: 945–953
Zhang J, Bao S, Furumai R, et al. Protein phosphatase 5 is required for ATR-mediated checkpoint activation. Mol Cell Biol, 2005, 25: 9910–9919
Ali A, Zhang J, Bao S, et al. Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes Dev, 2004, 18: 249–254
Kang Y, Cheong H M, Lee J H, et al. Protein phosphatase 5 is necessary for ATR-mediated DNA repair. Biochem Biophys Res Commun, 2011, 404: 476–481
Yong W, Bao S, Chen H, et al. Mice lacking protein phosphatase 5 are defective in ataxia telangiectasia mutated (ATM)-mediated cell cycle arrest. J Biol Chem, 2007, 282: 14690–14694
Kang Y, Lee J H, Hoan N N, et al. Protein phosphatase 5 regulates the function of 53BP1 after neocarzinostatin-induced DNA damage. J Biol Chem, 2009, 284: 9845–9853
Golden T, Aragon I V, Rutland B, et al. Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer. Biochim Biophys Acta, 2008, 1782: 259–270
Fiscella M, Zhang H, Fan S, et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53- dependent manner. Proc Natl Acad Sci USA, 1997, 94: 6048–6053
Takekawa M, Adachi M, Nakahata A, et al. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J, 2000, 19: 6517–6526
Yamaguchi H, Minopoli G, Demidov O N, et al. Substrate specificity of the human protein phosphatase 2Cdelta, Wip1. Biochemistry, 2005, 44: 5285–5294
Wang A, Gu J, Judson-Kremer K, et al. Response of human mammary epithelial cells to DNA damage induced by BPDE: Involvement of novel regulatory pathways. Carcinogenesis, 2003, 24: 225–234
Harrison M, Li J, Degenhardt Y, et al. Wip1-deficient mice are resistant to common cancer genes. Trends Mol Med, 2004, 10: 359–361
Castellino R C, De Bortoli M, Lu X, et al. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D. J Neurooncol, 2008, 86: 245–256
Le Guezennec X, Bulavin D V. WIP1 phosphatase at the crossroads of cancer and aging. Trends Biochem Sci, 2010, 35: 109–114
Lu X, Nguyen T A, Moon S H, et al. The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metastasis Rev, 2008, 27: 123–135
Lindqvist A, de Bruijn M, Macurek L, et al. Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. EMBO J, 2009, 28: 3196–3206
Lu X, Nannenga B, Donehower L A. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev, 2005, 19: 1162–1174
Yamaguchi H, Durell S R, Chatterjee D K, et al. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases. Biochemistry, 2007, 46: 12594–12603
Lu X, Ma O, Nguyen T A, et al. The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell, 2007, 12: 342–354
Lu X, Bocangel D, Nannenga B, et al. The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol Cell, 2004, 15: 621–634
Craig A L, Chrystal J A, Fraser J A, et al. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members. Mol Cell Biol, 2007, 27: 3542–3555
Lee J H, Paull T T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science, 2005, 308: 551–554
Guo J Y, Yamada A, Kajino T, et al. Aven-dependent activation of ATM following DNA damage. Curr Biol, 2008, 18: 933–942
Lu X, Nguyen T A, Donehower L A. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D. Cell Cycle, 2005, 4: 1060–1064
Cha H, Lowe J M, Li H, et al. Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response. Cancer Res, 2010, 70: 4112–4122
Macurek L, Lindqvist A, Voets O, et al. Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene, 2010, 29: 2281–2291
Rogakou E P, Pilch D R, Orr A H, et al. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem, 1998, 273: 5858–5868
Paull T T, Rogakou E P, Yamazaki V, et al. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol, 2000, 10: 886–895
Rogakou E P, Boon C, Redon C, et al. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol, 1999, 146: 905–916
Chowdhury D, Keogh M C, Ishii H, et al. gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell, 2005, 20: 801–809
Kimura H, Takizawa N, Allemand E, et al. A novel histone exchange factor, protein phosphatase 2Cgamma, mediates the exchange and dephosphorylation of H2A-H2B. J Cell Biol, 2006, 175: 389–400
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Liu, B., Xu, X. Serine/threonine protein phosphatases in DNA damage response. Chin. Sci. Bull. 56, 3122–3131 (2011). https://doi.org/10.1007/s11434-011-4679-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-011-4679-5